Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Whether or not to give adjuvant chemotherapy for breast cancer.

× No keyword cloud information.

14 in total

Review 1. Pharmacologic treatment of chemotherapy-induced nausea and vomiting.

Authors: J J Fiore; R J Gralla
Journal: Cancer Invest Date: 1984 Impact factor: 2.176

2. Short- or long-term chemotherapy for node-positive breast cancer: LMF 6 versus 18 cycles. SAKK study 27/76.

Authors: W F Jungi; P Alberto; K W Brunner; B Mermillod; L Barrelet; F Cavalli
Journal: Recent Results Cancer Res Date: 1984

3. Combination chemotherapy as an adjuvant treatment in operable breast cancer.

Authors: G Bonadonna; E Brusamolino; P Valagussa; A Rossi; L Brugnatelli; C Brambilla; M De Lena; G Tancini; E Bajetta; R Musumeci; U Veronesi
Journal: N Engl J Med Date: 1976-02-19 Impact factor: 91.245

4. Antiemetic efficacy of dexamethasone. Randomized, double-blind, crossover study with prochlorperazine in patients receiving cancer chemotherapy.

Authors: M Markman; V Sheidler; D S Ettinger; S A Quaskey; E D Mellits
Journal: N Engl J Med Date: 1984-08-30 Impact factor: 91.245

5. Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer.

Authors: G Bonadonna; P Valagussa; A Rossi; G Tancini; C Brambilla; M Zambetti; U Veronesi
Journal: Breast Cancer Res Treat Date: 1985 Impact factor: 4.872

6. Adjuvant tamoxifen in the management of operable breast cancer: the Scottish Trial. Report from the Breast Cancer Trials Committee, Scottish Cancer Trials Office (MRC), Edinburgh.

Authors:
Journal: Lancet Date: 1987-07-25 Impact factor: 79.321

Whether or not to give adjuvant chemotherapy for breast cancer.

Review 1. Pharmacologic treatment of chemotherapy-induced nausea and vomiting.

2. Short- or long-term chemotherapy for node-positive breast cancer: LMF 6 versus 18 cycles. SAKK study 27/76.

3. Combination chemotherapy as an adjuvant treatment in operable breast cancer.

4. Antiemetic efficacy of dexamethasone. Randomized, double-blind, crossover study with prochlorperazine in patients receiving cancer chemotherapy.

5. Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer.

6. Adjuvant tamoxifen in the management of operable breast cancer: the Scottish Trial. Report from the Breast Cancer Trials Committee, Scottish Cancer Trials Office (MRC), Edinburgh.

7. Adjuvant chemotherapy for breast cancer: side effects and quality of life.

8. Pituitary-ovarian function in breast cancer patients on adjuvant chemoimmunotherapy.

9. Mechanism of action of adjuvant chemotherapy in early breast cancer.

10. Effects of adjuvant chemohormonal therapy on the ovarian and adrenal function of breast cancer patients.